Genmab — Maj 2021
-
Og det er så hvad jeg håber på sker i 2. halvår
-
Jokeren er stadig voldgiften og dermed hexa
cd20 -
no, I don't know @Sukkeralf, have been pondering that question myself... and even though I consider Genmab only a tiny little bit Dutch as well, I feel I support the Dutch biotechs already by more then a normal fair share
lol -
-
Naturligvis sukker
-
-
If rHuPH20 exclusivity expires during this 10 year term. There is a step down in the royalty rate of approximately 50% from expiry until the end of the 10-year term. And it's this design that allows us to project meaningful royalty revenues even beyond 2027. And there's also the potential to obtain additional co-formulation patents on certain novel at partner product, potentially extending the mid single-digit royalty term up to 20 years post patent filing date.
-
While each agreement is negotiated separately, and terms and conditions vary across the agreements. In general, the core formulation patents have the favorable effect on the duration of the royalty term and potentially delay the timing of the royalty step down.
-
What have you guys been discussing today?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind